These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 25237864)

  • 41. Linking genomics and metabolomics to chart specialized metabolic diversity.
    van der Hooft JJJ; Mohimani H; Bauermeister A; Dorrestein PC; Duncan KR; Medema MH
    Chem Soc Rev; 2020 Jun; 49(11):3297-3314. PubMed ID: 32393943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of novel fungal RiPP biosynthetic pathways and their application for the development of peptide therapeutics.
    Vogt E; Künzler M
    Appl Microbiol Biotechnol; 2019 Jul; 103(14):5567-5581. PubMed ID: 31147756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mining genomes to illuminate the specialized chemistry of life.
    Medema MH; de Rond T; Moore BS
    Nat Rev Genet; 2021 Sep; 22(9):553-571. PubMed ID: 34083778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Global biogeographic sampling of bacterial secondary metabolism.
    Charlop-Powers Z; Owen JG; Reddy BV; Ternei MA; Guimarães DO; de Frias UA; Pupo MT; Seepe P; Feng Z; Brady SF
    Elife; 2015 Jan; 4():e05048. PubMed ID: 25599565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determining microbial products and identifying molecular targets in the human microbiome.
    Joice R; Yasuda K; Shafquat A; Morgan XC; Huttenhower C
    Cell Metab; 2014 Nov; 20(5):731-741. PubMed ID: 25440055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomes to natural products PRediction Informatics for Secondary Metabolomes (PRISM).
    Skinnider MA; Dejong CA; Rees PN; Johnston CW; Li H; Webster AL; Wyatt MA; Magarvey NA
    Nucleic Acids Res; 2015 Nov; 43(20):9645-62. PubMed ID: 26442528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Engineering microbial cell factories for the production of plant natural products: from design principles to industrial-scale production.
    Liu X; Ding W; Jiang H
    Microb Cell Fact; 2017 Jul; 16(1):125. PubMed ID: 28724386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Directed evolution, natural products for cancer chemotherapy, and micro-biosensing robots.
    Daniels C; Ramos JL; Molina-Santiago C; Michán C
    Microb Biotechnol; 2011 May; 4(3):314-7. PubMed ID: 21518297
    [No Abstract]   [Full Text] [Related]  

  • 49. Diversity and distribution of biosynthetic gene clusters in agricultural soil microbiomes.
    Zhang Z; Zhang L; Zhang L; Chu H; Zhou J; Ju F
    mSystems; 2024 Apr; 9(4):e0126323. PubMed ID: 38470142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metagenomic approaches for exploiting uncultivated bacteria as a resource for novel biosynthetic enzymology.
    Wilson MC; Piel J
    Chem Biol; 2013 May; 20(5):636-47. PubMed ID: 23706630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Linking Genes to Molecules in Eukaryotic Sources: An Endeavor to Expand Our Biosynthetic Repertoire.
    Ganley JG; Derbyshire ER
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioactive natural products from novel microbial sources.
    Challinor VL; Bode HB
    Ann N Y Acad Sci; 2015 Sep; 1354():82-97. PubMed ID: 26509922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacterial pathogens: threat or treat (a review on bioactive natural products from bacterial pathogens).
    Maglangit F; Yu Y; Deng H
    Nat Prod Rep; 2021 Apr; 38(4):782-821. PubMed ID: 33119013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. eSNaPD: a versatile, web-based bioinformatics platform for surveying and mining natural product biosynthetic diversity from metagenomes.
    Reddy BV; Milshteyn A; Charlop-Powers Z; Brady SF
    Chem Biol; 2014 Aug; 21(8):1023-33. PubMed ID: 25065533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using natural products for drug discovery: the impact of the genomics era.
    Zhang MM; Qiao Y; Ang EL; Zhao H
    Expert Opin Drug Discov; 2017 May; 12(5):475-487. PubMed ID: 28277838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Present and future outlooks on environmental DNA-based methods for antibiotic discovery.
    Rosenzweig AF; Burian J; Brady SF
    Curr Opin Microbiol; 2023 Oct; 75():102335. PubMed ID: 37327680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Omics-based natural product discovery and the lexicon of genome mining.
    Machado H; Tuttle RN; Jensen PR
    Curr Opin Microbiol; 2017 Oct; 39():136-142. PubMed ID: 29175703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toward a global picture of bacterial secondary metabolism.
    Seyedsayamdost MR
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):301-311. PubMed ID: 30684124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bio-mining the microbial treasures of the ocean: new natural products.
    Imhoff JF; Labes A; Wiese J
    Biotechnol Adv; 2011; 29(5):468-82. PubMed ID: 21419836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biodiversity in production of antibiotics and other bioactive compounds.
    Mahajan G; Balachandran L
    Adv Biochem Eng Biotechnol; 2015; 147():37-58. PubMed ID: 24840777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.